patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · small molecule
Anti-inflammatory
pre_registrationupdated 2mo agoby AimMax Therapeutics Inc🔗 ChEMBL
community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 11 investigational indications.
targets
Mitogen-activated protein kinase 11Mitogen-activated protein kinase 14
all catalysts(0)
nothing on the calendar yet
News(1)
- Sanofi posts upbeat sales as R&D pressure builds<figure><div><img src="https://imgproxy.divecdn.com/4sV6C1TzSj2YZ2rz0W5-EST8xmsio5JNKmZoYu-be_8/g:nowe:0:87/c:520:294/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…biopharma_dive · 2mo ago
comments(0)
5-min edit window · permanent after that